CORRECTING and REPLACING - PIMCO Canada Corp. Announces

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
23
CORRECTING and REPLACING - PIMCO Canada Corp. Announces Monthly Distributions for PIMCO Canada Exchange Traded Series

Not for distribution to United States newswire services or for dissemination in the United States

TORONTO, Feb. 14, 2019 (GLOBE NEWSWIRE) -- In a release issued February 13 by PIMCO Account Management please note the Cash Distribution per Unit rates in the table have changed. The corrected release follows: 

PIMCO Canada Corp. (“PIMCO Canada”) today announced the February 2019 cash distributions for the ETF series (“ETF Series”) of the PIMCO Canada mutual funds that distribute monthly (“Funds”). Unitholders of record of the ETF Series, at the close of business on February 21, 2019, will receive per-unit cash distribution payable on February 28, 2019.  This press release replaces the press release issued on February 13, 2019.

Details of the per-unit cash distribution amount are as follows:

Fund Name Ticker  Cash Distribution per Unit
PIMCO Monthly Income Fund (Canada) PMIF $  0.04840
PIMCO Investment Grade Credit Fund (Canada) IGCF $  0.04729
PIMCO Monthly Income Fund (Canada) US$ PMIF.U  US$ 0.03055

The Manager, PIMCO Canada administers and manages the PIMCO Canada ETFs, and retains Pacific Investment Management Company, LLC, (“PIMCO”), to provide sub-advisory services to the Funds.

About PIMCO

PIMCO is one of the world’s premier fixed income investment managers. With our launch in 1971 in Newport Beach, California, PIMCO introduced investors to a total return approach to fixed income investing. In the 45+ years since, we have continued to bring innovation and expertise to our partnership with clients seeking the best investment solutions. Today we have offices across the globe and 2,150+ professionals united by a single purpose: creating opportunities for investors in every environment. PIMCO is owned by Allianz S.E., a leading global diversified financial services provider.

Forward-Looking Statements

Certain statements included in this news release constitute forward-looking statements, including, but not limited to, those identified by the expressions “expect”, “intend”, “will” and similar expressions to the extent they relate to the Funds.  The forward-looking statements are not historical facts but reflect the Funds’, PIMCO Canada’s and/or PIMCO’s current expectations regarding future results or events.  These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations, including, but not limited to, market factors.  Although the Funds, PIMCO Canada and/or PIMCO believes that the assumptions inherent in the forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance and, accordingly, readers are cautioned not to place undue reliance on such statements due to the inherent uncertainty therein.  The Funds, PIMCO Canada and/or PIMCO undertakes no obligation to update publicly or otherwise revise any forward-looking statement or information whether as a result of new information, future events or other factors which affect this information, except as required by law.

Commissions, management fees and expenses all may be associated with an investment in the ETF Series Units. Please read the prospectus and ETF Facts carefully before investing. The ETF Series Units are not guaranteed, their value may change frequently and past performance may not be repeated.

For a summary of the risks of an investment in the fund, please see the specific risks of mutual funds section of the prospectus. Units of ETF Series trade like stocks, fluctuate in market value and may trade at a discount to their net asset value, which may increase risk of loss. Distributions are not guaranteed and are subject to change and/or elimination.

The products and services provided by PIMCO Canada may only be available in certain provinces or territories of Canada and only through dealers authorized for that purpose. PIMCO Canada has retained PIMCO LLC as sub-adviser. PIMCO Canada will remain responsible for any loss that arises out of the failure of its sub-adviser.

Contact:
Agnes Crane
PIMCO – Media Relations Phone: +212 597.1054
Email: agnes.crane@pimco.com

 

Scroll down for more posts ▼

Top 10 Most Recent News Articles

USPS Honors 150 Years of the U.S. Coast Guard Academy

Updated Category News Views 7

Honoring Tradition and Service The good ol’ U.S. Postal Service is at it again, giving a tip of the hat to a slice of American military heritage. This time, they’re putting out a new stamp to celebrate the 150th anniversary of the U.S. Coast Guard Academy. And you know where they did the honors? Right there on Custom House Pier in New London, Connecticut, a place that...

Continue Reading
U.S. Green Beret's Mission: Clearing Landmines in Ukraine

Updated Category News Views 3

The Rise of "Safe Ground" on Prime Video This isn't your typical feel-good story—it’s about grit and the unending fight for 'normalcy' where war left scars. Safe Ground, now streaming on Prime Video, showcases Ryan Hendrickson, a U.S. Army Green Beret whose story takes a sharp turn after stepping on an IED in 2010. The day he almost became just another statistic...

Continue Reading
D-Wave Faces Legal Questions After CFO Exit and Losses

Updated Category News Views 3

Trouble Brews at D-Wave Quantum Smack in the middle of market chaos, D-Wave Quantum Inc. (NASDAQ: QBTS) seems to have hit a rather gnarly pothole. With disappointing revenue figures for Q2 of 2026—coming in at a measly $3.08 million, far below the expected range of $4.03 million to $4.08 million—investors have more than enough reasons to be irked. When the numbers...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Damp or Dry: The Battle for Healthy Air in Colorado

Updated Category News Views 5

The Hidden Cost of Colorado's Dry Air Dry climate isn't just a seasonal inconvenience—it's a real hidden cost to living comfortably and healthily in Colorado. With winters colder than a brass monkey's tail and summers that don't offer much relief in terms of humidity, your home's air quality is on the front line. So, what's the financial tale here, and how do you come...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 4

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PureHealth's Acid Reflux Solutions: An Investor's Insight

Updated Category News Views 4

Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 6

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 5

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Pizza: The Unlikely Symbol of Universal Togetherness

Updated Category News Views 6

Why Pizza Is More Than Just Food They say a slice of pizza can tell a story. Whether it's a late-night snack amongst college buddies or the centerpiece of a family's Friday tradition, pizza unites like few others can. It morphs from a study aid into a tool for togetherness without skipping a beat, much like a chameleon of the food world. And no one understands this better...

Continue Reading

Top 5 Most Recently Viewed Articles

AI Alliance Introduces Game-Changing Tools and Expands

Updated Category News Views 289

AI Alliance Launches Innovative Programming Language and Framework Today marked a significant advancement in the world of artificial intelligence as the AI Alliance, a global non-profit organization committed to the evolution of open-source AI, unveiled groundbreaking initiatives. The introduction of Dana, an AI-powered programming language, alongside the OpenDXA agent...

Continue Reading
FDA Approves Repatha for Adults with High LDL-C Risks

Updated Category News Views 245

FDA Broadens Repatha Approval for Cardiovascular Risk Recently, the FDA has expanded the therapeutic indications for Repatha (evolocumab), allowing it to be prescribed to adults at a heightened risk of major adverse cardiovascular events (MACE) due to uncontrolled low-density lipoprotein cholesterol (LDL-C), often referred to as 'bad cholesterol.' This significant update...

Continue Reading
Nikola Corp Strengthens Financial Strategy with Updated Equity Deal

Updated Category News Views 116

Nikola Corporation's Strategic Financial Update Nikola Corporation (NASDAQ:NKLA), renowned for its commitment to zero-emission vehicle manufacturing, has made significant adjustments to its equity distribution agreement with Citigroup Global Markets Inc. This change was detailed in a recent filing, affirming the company's proactive approach to managing its financial...

Continue Reading
Exploring the Future of the Emergency Food Market Growth

Updated Category News Views 243

Understanding the Emergency Food Market Expansion The global emergency food market is on the brink of a significant transformation as it is projected to grow by an impressive USD 3.20 billion over the period from 2024 to 2028. With a compound annual growth rate (CAGR) of approximately 7.35%, this market is witnessing a shift driven by the organized retail sector's growth...

Continue Reading
Innovative Robotics: KEENON Launches Humanoid and Lawn Mower

Updated Category News Views 166

KEENON Robotics Makes Waves at CES with New Innovations At the recent tech event, KEENON Robotics, a pioneer in the field of service robotics, took center stage by unveiling its latest creations: the humanoid robot XMAN-R1 and the fully autonomous lawn mower known as KEENMOW K1. This showcase reflects KEENON's commitment to innovation and its mission to improve everyday...

Continue Reading